Ocular Therapeutix: Q1 Earnings Snapshot

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Tuesday reported a loss of $64.8 million in its first quarter.

On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 49 cents. Losses, adjusted to extinguish debt and for non-recurring costs, were 24 cents per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

The biotechnology company posted revenue of $14.8 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $15.4 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up